Literature DB >> 3119471

The role of gamma-interferon, vitamin D3 metabolites and tumour necrosis factor in the pathogenesis of tuberculosis.

G A Rook1, J Taverne, C Leveton, J Steele.   

Abstract

Endotoxin (LPS)-triggered release of tumour necrosis factor (TNF) from human monocytes is high for the first 3 days in culture, and then falls to a trough between Days 4 and 6. This trough is less deep if the cells are cultured in the presence of indomethacin. If monocytes are cultured in the presence of either recombinant gamma-interferon or 1,25-(OH)2 vitamin D3, their capacity for LPS-triggered TNF release is increased. Live virulent Mycobacterium tuberculosis can substitute for the LPS, and is markedly more effective as a trigger than several strains of BCG prepared in an identical manner. Since secretion of IFN-gamma and conversion of circulating 25-(OH) vitamin D3 to the active dihydroxy metabolite by interferon-activated macrophages probably occur in tuberculosis, we suggest that triggering of TNF release from the resulting activated macrophage populations might explain much of the weight loss and tissue damage that characterize this disease. IFN-gamma does not activate effective anti-mycobacterial mechanisms in human monocytes, so its role in tuberculosis may be immunopathological rather than protective.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3119471      PMCID: PMC1453980     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  31 in total

1.  Non-reactive tuberculosis.

Authors:  J R O'BRIEN
Journal:  J Clin Pathol       Date:  1954-08       Impact factor: 3.411

2.  [Does calciferol have a liquifying action on caseum?].

Authors:  J Brincourt
Journal:  Poumon Coeur       Date:  1967

3.  The dissociation of adjuvant properties of mycobacterial components from mitogenicity, and from the ability to induce the release of mediators from macrophages.

Authors:  G A Rook; D E Stewart-Tull
Journal:  Immunology       Date:  1976-09       Impact factor: 7.397

4.  Malarial parasites and tumour cells are killed by the same component of tumour necrosis serum.

Authors:  J Taverne; N Matthews; P Depledge; J H Playfair
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

5.  Physiological and pharmacological regulation of prostaglandin and leukotriene production by macrophages.

Authors:  R J Bonney; J L Humes
Journal:  J Leukoc Biol       Date:  1984-01       Impact factor: 4.962

6.  Production of an anti-tumour cytotoxin by human monocytes.

Authors:  N Matthews
Journal:  Immunology       Date:  1981-09       Impact factor: 7.397

7.  Interferon-gamma reduces macrophage-suppressive activity by inhibiting prostaglandin E2 release and inducing interleukin 1 production.

Authors:  D Boraschi; S Censini; A Tagliabue
Journal:  J Immunol       Date:  1984-08       Impact factor: 5.422

8.  Interferon as a macrophage activating factor. I. Enhancement of cytotoxicity by fresh and matured human monocytes in the absence of other soluble signals.

Authors:  R T Dean; J L Virelizier
Journal:  Clin Exp Immunol       Date:  1983-03       Impact factor: 4.330

9.  Production of an anti-tumour cytotoxin by human monocytes: comparison of endotoxin, interferons and other agents as inducers.

Authors:  N Matthews
Journal:  Br J Cancer       Date:  1982-04       Impact factor: 7.640

10.  1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells.

Authors:  D J Mangelsdorf; H P Koeffler; C A Donaldson; J W Pike; M R Haussler
Journal:  J Cell Biol       Date:  1984-02       Impact factor: 10.539

View more
  66 in total

Review 1.  Tumour necrosis factor-alpha inhibitors and the reactivation of latent tuberculosis infection.

Authors:  Richard Long; Michael Gardam
Journal:  CMAJ       Date:  2003-04-29       Impact factor: 8.262

2.  Impairment of cytokine production in mice fed a vitamin D3-deficient diet.

Authors:  M Kankova; W Luini; M Pedrazzoni; F Riganti; M Sironi; B Bottazzi; A Mantovani; A Vecchi
Journal:  Immunology       Date:  1991-08       Impact factor: 7.397

3.  Noninvasive pulmonary [18F]-2-fluoro-deoxy-D-glucose positron emission tomography correlates with bactericidal activity of tuberculosis drug treatment.

Authors:  Stephanie L Davis; Eric L Nuermberger; Peter K Um; Camille Vidal; Bruno Jedynak; Martin G Pomper; William R Bishai; Sanjay K Jain
Journal:  Antimicrob Agents Chemother       Date:  2009-09-08       Impact factor: 5.191

4.  Autocrine regulation of 1,25-dihydroxycholecalciferol metabolism in myelomonocytic cells.

Authors:  M Hewison; S Barker; A Brennan; J Nathan; D R Katz; J L O'Riordan
Journal:  Immunology       Date:  1989-10       Impact factor: 7.397

Review 5.  Coccidioidomycosis: host response and vaccine development.

Authors:  Rebecca A Cox; D Mitchell Magee
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

6.  c-fos and tumor necrosis factor gene expression in Leishmania donovani-infected macrophages.

Authors:  A Descoteaux; G Matlashewski
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

7.  Growth hormone activation of human monocytes for superoxide production but not tumor necrosis factor production, cell adherence, or action against Mycobacterium tuberculosis.

Authors:  J Warwick-Davies; D B Lowrie; P J Cole
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

8.  Mechanisms of stimulation of interleukin-1 beta and tumor necrosis factor-alpha by Mycobacterium tuberculosis components.

Authors:  Y Zhang; M Doerfler; T C Lee; B Guillemin; W N Rom
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

9.  Regulation of murine macrophage effector functions by lipoarabinomannan from mycobacterial strains with different degrees of virulence.

Authors:  L B Adams; Y Fukutomi; J L Krahenbuhl
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

10.  Effect of lipoarabinomannan and mycobacteria on tumour necrosis factor production by different populations of murine macrophages.

Authors:  M G Bradbury; C Moreno
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.